MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001: Shanghai Saturday, February 28, 2026, 18:00 Hrs [IST] MindRank, a cli ...
How companies are moving beyond assistive tools to deploying agentic systems, and marking a fundamental shift in how they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results